Molecular characterization of cell types using single-cell transcriptome sequencing is
revolutionizing cell biology and enabling new insights into the physiology of human organs. We …

Despite impressive progress, more than 50% of patients treated with CD19-targeting chimeric
antigen receptor T cells (CAR19) experience progressive disease. Ten of 16 patients with …

Cell culture is an essential tool in drug discovery, tissue engineering and stem cell research.
Conventional tissue culture produces two-dimensional cell growth with gene expression, …

Merging tumor targeting and molecular-genetic imaging into an integrated platform is limited
by lack of strategies to enable systemic yet ligand-directed delivery and imaging of specific …

Biological molecular assemblies are excellent models for the development of nanoengineered
systems with desirable biomedical properties. Here we report an approach for fabrication …

Artificial intelligence (AI) algorithms continue to rival human performance on a variety of clinical
tasks, while their actual impact on human diagnosticians, when incorporated into clinical …

The management of CNS tumors is limited by the blood-brain barrier (BBB), a vascular interface
that restricts the passage of most molecules from the blood into the brain. Here we show …

We show that a membrane-associated protease, aminopeptidase A (APA), is upregulated
and enzymatically active in blood vessels of human tumors. To gain mechanistic insight, we …

The prognosis of patients with large B-cell lymphoma (LBCL) that progresses after treatment
with chimeric antigen receptor (CAR) T-cell therapy targeting CD19 (CAR19) is poor. We …

Aminopeptidase N (APN, CD13; EC 3.4.11.2) is a transmembrane metalloprotease with several
functions, depending on the cell type and tissue environment. In tumor vasculature, APN …